Serum Cystatin C in Chronic Kidney Disease: A Case-Control Study
Background: Chronic kidney disease (CKD) is a major public health concern in recent years mainly due to its adverse clinical outcomes. It is most commonly attributed to diabetes mellitus (DM) and hypertension (HTN). Among the several novel biomarkers discovered to detect impaired renal function, ser...
Main Authors: | Sukanya Shetty, Janice DSa, Tirthal Rai, Srinidhi Rai, Roopa Bhandary |
---|---|
Format: | Article |
Language: | English |
Published: |
Hamadan University of Medical Sciences
2021-12-01
|
Series: | Avicenna Journal of Medical Biochemistry |
Subjects: | |
Online Access: | http://ajmb.umsha.ac.ir/PDF/ajmb-9-83.pdf |
Similar Items
-
Comparison of cardiovascular event predictability between the 2009 and 2021 Chronic Kidney Disease Epidemiology Collaboration equations in a Korean chronic kidney disease cohort: the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease study
by: Ji Hye Kim, et al.
Published: (2023-11-01) -
Cystatin C: A Marker of Renal Function
by: Md Aminul Haque Khan, et al.
Published: (2014-05-01) -
Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
by: Kwang-Sook Woo, et al.
Published: (2014-08-01) -
Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
by: Jung Nam An, et al.
Published: (2022-09-01) -
Comparison of Serum Cystatin C and Creatinine Levels to Evaluate Early Renal Function after Kidney Transplantation
by: Hamid Eshraghi, et al.
Published: (2009-06-01)